Success Stories: EB-1A Petition Approved for an Assistant Professor in Michigan in the Field of Pediatric Pulmonology
Client’s Testimonial:
I am very happy to inform you that my case status shows- Approved. I really appreciate your great work.
EB1-A (Alien of Extraordinary Ability) Approval Received on December 6th, 2013 for an Assistant Professor in the Field of Pediatric Pulmonology (Approval Notice)
General Field: Pediatric Pulmonology
Position at the Time of Case Filing: Assistant Professor
National Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Michigan
Approval Notice Date: December 6, 2013
Processing Time: 5 months, 22 days
Case Summary:
In this case, we had the opportunity to represent a distinguished Assistant Professor from India working in the field of pediatric pulmonology. He had specialized in investigations on Cystic Fibrosis, sweat testing, Asthma, chronic lung infections and inflammatory disorders, as well as Pulmonary Function Testing and flexible fiberoptic bronchoscopy. At the time we filed his case, his outstanding record of achievement included 210 citations distributed across 20 peer-reviewed publications, 10 book chapters, 2 conference presentations. In addition, he had reviewed a total of 30 manuscripts for publication in 6 distinct journals. This served as objective evidence of his sustained international acclaim and his major influence and impact on his field. In addition, he had worked as a reviewer in a leadership role, being one of the Associate Editors for an internationally-circulated journal. The value of his work is summarized by the following quote from an independent recommender, “The persistently superb quality of his research has made him indispensable to the field as a whole, and his work directly benefits global public health.” It was our aim to prove that our client qualified for classification as an Alien of Extraordinary Ability, as he sought to remain in the United States to continue working in the field of pediatric pulmonology, and that his continued work would substantially and prospectively benefit the United States. With the documentation that we provided, his case was approved in less than 6 months.

